SELLAS Life Sciences Group, Inc. (SLS) stock
SLSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$17.95−1.20 (-6.27%)
Close on Nov 18, 2026Market cap $3.62BP/E –Yield –
SELLAS Life Sciences price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
SELLAS Life Sciences's price to sales ratio was 29.5× on Apr 28, 2023, against 5.7× a year earlier. Over the last 2 years it ranged from 5.7× to 489.6×, with a median of 23.7×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2023 | Apr 28, 2023 | 29.5× | −19.1 |
| 2022 | Dec 30, 2022 | 48.6× | +39.3 |
| 2021 | Dec 31, 2021 | 9.2× | −466.3 |
| 2015 | Apr 30, 2015 | 475.6× | – |
See a number that looks wrong?